Mostrando 2 resultados de: 2
Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile
ReviewAbstract: inTrodUCTion: The management of non-metastatic castration-resistant prostate cancer (nmCrpC) has undPalabras claves:Apalutamide, Castration, Darolutamide, Enzalutamide, Network meta-analysis, prostatic neoplasmsAutores:Briganti A., Diego M. Carrión, Egawa S., Esperto F., Fiori C., Grossmann N.C., Katayama S., Kimura T., Laukhtina E., Mori K., Mostafaei H., Motlagh R.S., Papalia R., Ploussard G., Pradere B., Quhal F., Rajwa P., Schuettfort V.M., Shariat S.F.Fuentes:scopusA gender-related dichotomy in bladder cancer
OtherAbstract:Palabras claves:Autores:Cimadamore A., del Giudice F., Di Trapani E., Diego M. Carrión, Krajewski W., Mori K., Moschini M., Tan W.S., Teoh J.Y.C.Fuentes:scopus